Published in Law and Health Weekly, May 1st, 2004
This patent, which was previously granted in the U.S., covers the composition of injectable naltrexone microspheres to reduce consumption of heroin and alcohol.
DrugAbuse Sciences holds an exclusive worldwide license from Southern Research Institute (Southern Research, Birmingham, Alabama, USA) to develop a long-acting version of Naltrexone based on these patents. DrugAbuse Sciences Naltrexone Depot product is currently evaluated in phase III...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.